The Molecular Genetic Peculiarities of Genomic Structure of Members of the Ebolavirus Genus

The molecular genetic peculiarities of genomic structure of the Ebolavirus genus members are viewed in the review. The Ebola virus disease outbreaks in West African countries constitute a threat not only for Africa, but for the whole world in view of possible introduction of the agent in non-endemic regions. The members of the Ebolavirus genus have different pathogenicity for humans, thus differ severity and mortality of the disease they cause. There is a significant genetic divergence among members of the Ebolavirus genus. The differences of pathogenic potential of members of the Ebolavirus genus may be explained as the result of mutations in the genes of virus structural proteins. It is possible, that some of these mutations may affect virulence of strains within one virus species. So far as most effective modern medicines for specific prophylaxis and treatment of Ebola fever are target-oriented, genotyping of the agent will promote elaboration of strategy of such preparations development.

вирус Эбола, филовирусы, секвенирование, ген, генотипирование, Ebola virus, filoviruses, sequencing, gene, genotyping

1. Albarino C.G., Shoemaker T., Khristova M.L., Wamala J.F., Muyembe J.J., Balinandi S. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology. 2013; 442:97–100.

2. Bao Y., Chetvernin V., Tatusova T. Pаirwise sequence comparison (PASC) and its application in the classification of filoviruses. Viruses. 2012; 4:1318–27.

3. Basler C., Mikulasova A., Masrtinez-Sobrido L., Paragas J., Muhlberger E., Bray M., Klenk H.D., Pales P., Garcia-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 2003; 77:7945–56.

4. Basler C., Wang X., Muhlberger E., Volchkov V., Paragas J., Klenk H., Garcia-Sastre A., Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA. 2000; 97:12289–94.

5. Biek R., Walsh P.D., Leroy E.M., Real L.A., Recent common ancestry of Ebola Zaire virus found in a bat reservoir. PLoS Pathog. 2006; 2:90.

6. Carroll S.A., Towner J.S., Sealy T.K., McMullan L.K., Khristova M.L., Burt F.J., Swanepoel R., Rollin P.E., Nichol S.T. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J. Virol. 2013; 87:2608–16.

7. Ebihara H., Takada A., Kobassa D., Jones S., Neumann G., Theriault S., Bray M., Feldmann H., Kawaoka Y. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2006; 2(7):73.

8. Feldmann H., Geisbert T.W. Ebola hemorrhagic fever. Lancet. 2011; 377:849–62.

9. Grard G., Biek R., Tamfum J.J., Fair J., Wolfe N., Formenty P., Paweska J., Leroy E. Emergence of divergent Zaire Ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. J. Infect. Dis. 2011; 204(3):776–84.

10. Grolla A., Lucht A., Dick D., Strong J.E., Feldman H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull. Soc. Pathol. Exot. 2005; 98:205–9.

11. Gure S.K., Goba A., Andersen K.G., Sealfon R.S.G., Parc D.J., Kanneh L., Jalloh S., Momoh M., Fullah M., Dudas G., Wohl S., Moses L.M., Yozwiak N.L., Winnicki S., Matranga C.B., Malboeuf C.M., Qu J., Gladden A.D., Schaffner S.F., Yang X., Jiang P.P., Nekoui M., Colubri A., Coomber M.R., Fonnie M., Moigboi A., Gbakie M., Kamara F.K., Tucker V., Yillah M., Kanneh F., Robert F., Massally J.L., Chapman S.B., Bochicchio J., Murphy C., Nusbaum C., Young S., Birren B.W., Grant D.S., Scheiffellin L.S., Lander E.S., Happi C., Gevao S.M., Gnirke A., Rambaut A., Garry R.F., Khan S.H., Sabeti P.C. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014; 345:1369–72.

12. Lauber C., Gorbalenya A.E. Genetics-Based Classification of Filoviruses Calls for Expanded Sampling of Genomic Sequences. Viruses. 2012; 4:1425–37.

13. Leroy E.M., Baize S., Mavoungou E., Apetrey C. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceases, surviving and asymptomatically infeсted individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. J. Gen. Virol. 2002; 83:56–73.

14. Leroy E.M., Baize S, Volchkov V.E., Fisher-Hoch S. P., Georges-Courbot M. C., Lansoud-Soukate J., Capron M., Debre P., McCormick J. B., Georges A. J. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000; 355:2210–15.

15. Mateo M., Carbonelle C., Reynard O., Kolesnikova L., Nemirov K., Page A., Volchkova V.A., Volchkov V.E. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. J. Infect. Dis. 2011; 204(3):1011–20.

16. Mingo R.M., Simmons J.A., Shoemaker C.J., Nelson E.A., Schornberg K.L., D’Souza R., Casanova J.E., White J.M. Ebola virus and severe acute respiratory syndrome Coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J. Virol. 2015; 89(5):2931–43.

17. Pourrut X., Kumulungui B., Wittmann T., Moussavou G., Delicat A., Yaba P., Nkoghe D., Gonzalez J.P., Leroy E.M. The natural history of Ebola virus in Africa. Microbes Infect. 2005; 7(7–8):1005–14.

18. Prins K.S., Delpeut S., Leung D.W., Reunard O., Volebkova V.A., Reid S.P., Ramanan P., Cardenas W.B., Amarasinghe G.K., Volchov V.E., Basler C.F. Mutations abrogating VP 35 interaction with double stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 2010; 84:3004–15.

19. Reid S.P., Leung D.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin alpha 1 and blocks STATi nuclear accumulation. J. Virol. 2006; 80:5156–67.

20. Rodriguez L., De Roo A., Guimard Y., Trappier S., Sanchez A., Bressler D., Williams A., Rowe A., Bertolli J., Khan A., Ksiazek T., Peters C., Nichol S. Persistence and genetic stability of Ebola virus during the outbreak in the Democratic Republic of the Congo, 1995. J. Infect. Dis. 1995; 179:170–6.

21. Suzuki Y., Gojobori T. The origin and evolution of Ebola and Marburg viruses. Mol. Biol. Evol. 1997; 14:800–6.

22. Volchov V.E., Chepurnov A.A., Volchova V.A., Ternovoj V.A., Klenk H.D. Molecular characterization guinea pig-adapted variants of Ebola virus. Virology. 2000; 277:147–55.

23. Volchkov V.E., Feldmann H., Volchkova V.A., Klenk H.D. Processing of Ebola virus glycoprotein be polyprotein convertase furin. Proc. Nat. Acad. Sci. USA. 1998; 95:5762–67.

24. Yang Z.Y., Duckers H.J., Sullivan N.J., Sanchez A., Nabel E.G., Nabel G.J. Identification of the Ebola virus glycoprotein as main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 2000; 6:886–9.